Indian clinics market pre-wedding weight-loss packages with Mounjaro and Wegovy India obesity drugs market seen reaching $860.34 million by 2030 Drug regulator raises concerns over potential misuse as ...

A first-of-its-kind weight loss pill will become the latest drug to be offered on President Trump's cost comparison platform "Trump Rx," CBS News exclusively learned. Foundayo, a GLP-1 drug, is a ...

Eli Lilly’s once-daily pill for weight loss got approval from U.S. drug regulators Wednesday. The all-clear sets up a battle with rival Novo Nordisk, which has been selling a pill version of its ...

For decades, beta-blockers have been routinely prescribed after low-risk heart attacks and often continued for life to prevent future events. But emerging research is now reexamining typical ...

A study published in the New England Journal of Medicine suggests heart attack survivors might eventually be able to stop taking beta-blockers. Trump accused of bombing another school with ‘untested’ ...

Jimmie Wilson is president of the JADA Foundation. Millions of Americans have increasingly turned to GLP-1 medications to lose weight and improve their health. These drugs have transformed treatment ...

For decades, surviving a heart attack has come with a lifelong prescription: Stay on medications called beta-blockers to help protect your heart. But doctors are taking a closer look at whether ...

NEW ORLEANS, LA—Taking stabilized patients off long-term beta-blocker therapy after MI without evidence of heart failure or left ventricular dysfunction does not result in any adverse clinical ...

For decades, beta-blockers have been commonly prescribed as a standard treatment for adults who have had heart attacks with no complications, and many people continue the medications for life. But a ...